Anti-IRF3 antibody [RP23040263]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Multiclonal IRF3 antibody. Suitable for ICC/IF, WB and reacts with Human samples. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human IRF3.
View Alternative Names
Interferon regulatory factor 3, IRF-3, IRF3
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-IRF3 Antibody [RP23040263] (AB313423)
Immunofluorescent analysis of A549 cells fixed with 4% formaldehyde reconstituted in 1X PBS for 10 min at room temperature and permeabilized with 0.1 % Triton X-100 in PBS for 15 min at room temperature labeling endogenous IRF3 with ab313423 at 1/100 dilution followed by Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor® 488 conjugate at 1/2000 dilution. Nuclei (blue) were stained using DAPI and cytoskeletal F-actin (red) staining using Rhodamine Phalloidin at 1/300 dilution. Panel a-d) shows representative untransfected cells that were stained for detection and localization of IRF3 protein (green) with cytoplasmic signal compared to panel e-h) clearly demonstrating translocation and localisation of IRF3 in nucleus of A549 cells transfected with Poly (dA : dT) (2µg/mL, 4h). The images were captured at 60X magnification.
- WB
Supplier Data
Western blot - Anti-IRF3 Antibody [RP23040263] (AB313423)
All lanes:
Western blot - Anti-IRF3 Antibody [RP23040263] (ab313423) at 1/250 dilution
Lane 1:
A549 whole cell extract at 30 µg
Lane 2:
HCT 116 whole cell extract at 30 µg
Lane 3:
HeLa whole cell extract at 30 µg
Lane 4:
HT-29 whole cell extract at 30 µg
Lane 5:
MCF7 whole cell extract at 30 µg
Lane 6:
Hep G2 whole cell extract at 30 µg
Lane 7:
K-562 whole cell extract at 30 µg
Lane 8:
Jurkat whole cell extract at 30 µg
Secondary
All lanes:
Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1/4000 dilution
Observed band size: 47 kDa
false
Reactivity data
Product details
What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:
- - The sensitivity of polyclonal antibodies by recognising multiple epitopes
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
View our range of recombinant multiclonal antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IRF3 participates in the regulation of type I interferon (IFN) response a fundamental antiviral defense mechanism. IRF3 when phosphorylated forms a complex with CBP/p300 which then translocates to the nucleus to drive the expression of IFN-stimulated genes. This action strengthens the innate immune response and boosts the body's ability to counteract viral infections. Its activity and regulation are significant for maintaining a balanced immune response without excessive inflammation.
Pathways
IRF3 is involved in the Toll-like receptor (TLR) and RIG-I-like receptor (RLR) signaling pathways both essential in pathogen recognition and response. Within these pathways IRF3 interacts with proteins such as MAVS and TBK1 to propagate immune signaling. The activation of IRF3 in these pathways results in the production of type I interferons and other cytokines orchestrating an effective antiviral response. These interactions highlight the protein's central role in mediating immune signaling cascades.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com